Close Menu

360Dx

Compared with RT-PCR testing, Abbott's BinaxNow test had a sensitivity of 64 percent for samples from symptomatic people and nearly 36 percent for asymptomatic people.

SureScreen's test will be deployed in educational settings, as well as for the testing of National Health Service and care home staff.

The firm sells a rapid, point-of-care, PCR platform for infectious disease diagnostics, including SARS-CoV-2, influenza, respiratory syncytial virus, and Strep A.

The company launched in November a survey-based test for screening patients for preterm birth risk that it plans to pair with a mass spectrometry-based assay.